News
November 5, 2007 - New data released today at the American Heart Association's Scientific Sessions showed that Abbott's SIMCOR, an investigational, fixed-dose combination of Abbott's proprietary extended-release niacin, Niaspan, and simvastatin, met its primary endpoint of lowering plaque-promoting non-HDL cholesterol (total cholesterol minus HDL), while demonstrating improvements on other key lip
November 05, 2007
News
November 6, 2007 – Philips Medical Systems at AHA highlighted its recently introduced iE33 Live 3D TEE, an echo system ...
November 05, 2007News
November, 2007 - An ECG that fits in the palm of your hand, Mortara Instrument’s ELI 10 hand-held electrocardiograph includes a variety of advanced clinical and communication features.
November 05, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
November 4, 2007 - Itamar Medical announced that four presentations at AHA, including one from the Framingham Heart ...
November 05, 2007News
November 6, 2007 - Acusphere Inc. announced that Imagify Perfusion Stress Echo, an investigational new drug developed to ...
November 05, 2007Technology
Pinyons Medical Technology offers the FDA-cleared PowrSyringe Injector, a disposable hand-held device designed to offer ergonomic and mechanical advantages to inject and aspirate fluids including use in angiography. The Injector’s crossing handles hinge to the syringe barrel and plunger to advance the plunger into the barrel when the handles are squeezed.
November 04, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
November 5, 2007 - According to late-breaking clinical trial results presented at the American Heart Association’s ...
November 04, 2007News
November 5, 2007 – Boston Scientific Corp. highlighted at the American Heart Association conference its new Stentplus ...
November 04, 2007News
November 5, 2007 - A pooled analysis of the E-SIRIUS and C-SIRIUS trials, called New SIRIUS, found that the CYPHER sirolimus-eluting coronary stent continued to provide clinical benefits with similar safety compared to a bare metal stent at five-year follow-up, according to data presented at the American Heart Association Scientific Session 2007.
November 04, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
November 5, 2007 - Pinyons Medical Technology announced it received FDA clearance to market the PowrSyringe Injector, a ...
November 04, 2007News
November 4, 2007 - A small, implantable device that helps the heart pump blood works equally well for men and women but ...
November 03, 2007News
November 4, 2007 – A specific way of dosing eptifibatide appears equally effective as giving abciximab as an adjunct to ...
November 03, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
November 4, 2007 – The antiplatelet drug prasugrel offered greater benefit than current, standard therapy for patients ...
November 03, 2007News
November 4, 2007 – Drug-eluting stents to open blocked coronary arteries caused no more risks for death or heart attack than bare metal stents, according to a late-breaking outcomes trial presented at the American Heart Association’s Scientific Sessions 2007.
November 03, 2007News
November 4, 2007 - The prevalence of asymptomatic peripheral artery disease (PAD) is steadily increasing among American ...
November 03, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now